Search Results - "Buckley, R.H."

Refine Results
  1. 1
  2. 2

    Long-term Clinical Outcome of Patients with Severe Combined Immunodeficiency (SCID) after Non-Ablative Related Donor Bone Marrow Transplantation by Railey, M, Buckley, R.H

    Published in Journal of allergy and clinical immunology (01-02-2008)
    “…Rationale To evaluate the long term clinical outcome of 159 patients with SCID who were transplanted (143 with T cell-depleted haploidentical, 16 with…”
    Get full text
    Journal Article
  3. 3

    Family History and Low Absolute Lymphocyte Count (ALC) as Diagnostic Clues for Severe Combined Immunodeficiency (SCID) by McWilliams, L.M, McGoldrick, S, Railey, M.D, Buckley, R.H

    Published in Journal of allergy and clinical immunology (01-02-2008)
    “…Methods We reviewed original charts and electronic discharge summaries and labs from 90 patients who received either T cell-depleted haploidentical or…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Long-term outcome of non-ablative booster BMT in patients with SCID by Teigland, C L, Parrott, R E, Buckley, R H

    Published in Bone marrow transplantation (Basingstoke) (01-08-2013)
    “…SCID is a fatal syndrome caused by mutations in at least 13 different genes. It is characterized by the absence of T cells. Immune reconstitution can be…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Natural Killer T (NKT) Cell Development in Severe Combined Immunodeficiency (SCID) After T Cell Depleted Haploidentical Bone Marrow Transplantation (BMT) by Sajaroff, E.O., Buckley, R.H.

    Published in Journal of allergy and clinical immunology (01-02-2006)
    “…METHODS: 4-color flow cytometry was used to determine the percentages of CD3+CD16+and CD3+CD56+ NKT cells and CD3-CD16+ and CD3-CD56+ NK cells among blood…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Subcutaneous infusion of immune globulin in an infant with severe combined immunodeficiency (SCID) by Sedlak, D.A., Buckley, R.H.

    Published in Journal of allergy and clinical immunology (01-02-2005)
    “…Evaluate the subcutaneous method of Immune globulin administration in an infant with Severe Combined Immunodeficiency (SCID) in the post-transplant period. For…”
    Get full text
    Journal Article
  10. 10

    CD4+CD25high T regulatory cells in SCID patients post-bone marrow transplantation (BMT) by Sajaroff, E.O., Coyne, K.E., Buckley, R.H.

    Published in Journal of allergy and clinical immunology (01-02-2005)
    “…Three of them showed by 30-60 days post-BMT an elevated % of CD4+CD25high T cells that decreased with time while immune function increased…”
    Get full text
    Journal Article
  11. 11

    Intracellular cytokine production by T cells in SCID infants with time post-bone marrow transplantation (BMT) by Sajaroff, E.O., Buckley, R.H.

    Published in Journal of allergy and clinical immunology (01-02-2004)
    “…To assess whether there is immune deviation in T cells of SCIDs with time post-BMT, intracellular cytokine production by T cells was studied. PBMC were…”
    Get full text
    Journal Article
  12. 12

    Successful HLA-identical bone marrow transplantation in a patient with interferon-γ receptor 2 deficiency and disseminated Mycobacterium avium complex infection by Scurlock, A.M., Sajaroff, E.O., Rosenzweig, S.D., Martin, P.L., Holland, S.M., Buckley, R.H.

    “…Interferon gamma receptor-2 (IFNγR2) deficiency is characterized by increased susceptibility to nontuberculous mycobacteria and intracellular pathogens. We…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Natural killer (NK) cells and bone marrow transplant (BMT) in severe combine combined immunodeficiency (SCID) by Piltch, R.G., Grambow, S.C., Buckley, R.H.

    Published in Journal of allergy and clinical immunology (01-02-2004)
    “…Natural killer (NK) cells are thought to have a possible role in marrow graft acceptance; little has been published about NK effects in SCID patients before…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Ex vivo gene therapy of two children with X-linked severe combined immunodeficiency by Chinen, J., Davis, J., Linton, G.F., Theobald-Whitting, N.L., Woltz, P.C., Buckley, R.H., Malech, H.L., Puck, J.M.

    Published in Journal of allergy and clinical immunology (01-02-2005)
    “…Bone marrow transplantation (BMT) for XSCID is not fully satisfactory because most patients lack an HLA-matched relative and receive HLA-haploidentical BMTs,…”
    Get full text
    Journal Article
  19. 19
  20. 20